Psychosocial factors and treatment satisfaction after radical prostatectomy

Shilajit D Kundu*, David E Victorson, John O. DeLancey, James L. Burns, Lauren Languido, Zeeshan Butt, Sandra Gutierrez, Azra Muftic, Kevin T. McVary, Kent T Perry Jr, Robert B Nadler, Edward Matthew Schaeffer, Anthony J Schaeffer, David Cella

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Sexual and urinary side effects of prostate cancer treatment have been well described in the literature, but less is known about the psychosocial effects of prostate cancer treatment. Objective To prospectively evaluate physical and psychosocial functioning after diagnosis of prostate cancer and factors associ-ated with treatment satisfaction after prostate cancer treatment. Methods Patients diagnosed with prostate cancer at a university-based urology department were invited to participate in this internet-based study. Validated questionnaires were used to evaluate health-related quality of life (HRQoL) domains at pretreatment baseline following diagnosis and at 1, 3, 6, and 12 months after treatment. Domains of HRQoL included sexual, urinary, and bowel functioning; anxiety and depression; and sleep disturbance, pain, and fatigue. Linear repeated measures models were used to examine changes in self-reported measures at each time point. Results Of 105 men diagnosed with prostate cancer enrolled in the study, 54 completed assessments through 12 months. Decreased erectile function and sexual HRQoL following treatment were not significantly associated with worse treatment satisfac-tion over time. Instead, treatment satisfaction was significantly associated (P < .01) with anxiety (r, .28-.60), depression (r, .32-.48), fatigue (r, .40-.56), pain (r, .32-.61), sleep disturbance (r, .51-.59), and bladder problems (r, .41-.63). Limitations Not all patients were enrolled or completed all longitudinal questionnaires, which may bias the results because of unmeasurable factors. We were not able to.

Original languageEnglish (US)
Pages (from-to)e130-e137
JournalJournal of Community and Supportive Oncology
Volume16
Issue number3
DOIs
StatePublished - Jun 1 2018

Fingerprint

Prostatectomy
Psychology
Prostatic Neoplasms
Quality of Life
Therapeutics
Fatigue
Sleep
Anxiety
Depression
Pain
Reproductive Health
Urology
Internet
Urinary Bladder

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

@article{ef405a13373043fd90092160c993ddb1,
title = "Psychosocial factors and treatment satisfaction after radical prostatectomy",
abstract = "Sexual and urinary side effects of prostate cancer treatment have been well described in the literature, but less is known about the psychosocial effects of prostate cancer treatment. Objective To prospectively evaluate physical and psychosocial functioning after diagnosis of prostate cancer and factors associ-ated with treatment satisfaction after prostate cancer treatment. Methods Patients diagnosed with prostate cancer at a university-based urology department were invited to participate in this internet-based study. Validated questionnaires were used to evaluate health-related quality of life (HRQoL) domains at pretreatment baseline following diagnosis and at 1, 3, 6, and 12 months after treatment. Domains of HRQoL included sexual, urinary, and bowel functioning; anxiety and depression; and sleep disturbance, pain, and fatigue. Linear repeated measures models were used to examine changes in self-reported measures at each time point. Results Of 105 men diagnosed with prostate cancer enrolled in the study, 54 completed assessments through 12 months. Decreased erectile function and sexual HRQoL following treatment were not significantly associated with worse treatment satisfac-tion over time. Instead, treatment satisfaction was significantly associated (P < .01) with anxiety (r, .28-.60), depression (r, .32-.48), fatigue (r, .40-.56), pain (r, .32-.61), sleep disturbance (r, .51-.59), and bladder problems (r, .41-.63). Limitations Not all patients were enrolled or completed all longitudinal questionnaires, which may bias the results because of unmeasurable factors. We were not able to.",
author = "Kundu, {Shilajit D} and Victorson, {David E} and DeLancey, {John O.} and Burns, {James L.} and Lauren Languido and Zeeshan Butt and Sandra Gutierrez and Azra Muftic and McVary, {Kevin T.} and {Perry Jr}, {Kent T} and Nadler, {Robert B} and Schaeffer, {Edward Matthew} and Schaeffer, {Anthony J} and David Cella",
year = "2018",
month = "6",
day = "1",
doi = "10.12788/jcso.0401",
language = "English (US)",
volume = "16",
pages = "e130--e137",
journal = "Journal of Community and Supportive Oncology",
issn = "2330-7749",
publisher = "Frontline Medical Communications",
number = "3",

}

Psychosocial factors and treatment satisfaction after radical prostatectomy. / Kundu, Shilajit D; Victorson, David E; DeLancey, John O.; Burns, James L.; Languido, Lauren; Butt, Zeeshan; Gutierrez, Sandra; Muftic, Azra; McVary, Kevin T.; Perry Jr, Kent T; Nadler, Robert B; Schaeffer, Edward Matthew; Schaeffer, Anthony J; Cella, David.

In: Journal of Community and Supportive Oncology, Vol. 16, No. 3, 01.06.2018, p. e130-e137.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Psychosocial factors and treatment satisfaction after radical prostatectomy

AU - Kundu, Shilajit D

AU - Victorson, David E

AU - DeLancey, John O.

AU - Burns, James L.

AU - Languido, Lauren

AU - Butt, Zeeshan

AU - Gutierrez, Sandra

AU - Muftic, Azra

AU - McVary, Kevin T.

AU - Perry Jr, Kent T

AU - Nadler, Robert B

AU - Schaeffer, Edward Matthew

AU - Schaeffer, Anthony J

AU - Cella, David

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Sexual and urinary side effects of prostate cancer treatment have been well described in the literature, but less is known about the psychosocial effects of prostate cancer treatment. Objective To prospectively evaluate physical and psychosocial functioning after diagnosis of prostate cancer and factors associ-ated with treatment satisfaction after prostate cancer treatment. Methods Patients diagnosed with prostate cancer at a university-based urology department were invited to participate in this internet-based study. Validated questionnaires were used to evaluate health-related quality of life (HRQoL) domains at pretreatment baseline following diagnosis and at 1, 3, 6, and 12 months after treatment. Domains of HRQoL included sexual, urinary, and bowel functioning; anxiety and depression; and sleep disturbance, pain, and fatigue. Linear repeated measures models were used to examine changes in self-reported measures at each time point. Results Of 105 men diagnosed with prostate cancer enrolled in the study, 54 completed assessments through 12 months. Decreased erectile function and sexual HRQoL following treatment were not significantly associated with worse treatment satisfac-tion over time. Instead, treatment satisfaction was significantly associated (P < .01) with anxiety (r, .28-.60), depression (r, .32-.48), fatigue (r, .40-.56), pain (r, .32-.61), sleep disturbance (r, .51-.59), and bladder problems (r, .41-.63). Limitations Not all patients were enrolled or completed all longitudinal questionnaires, which may bias the results because of unmeasurable factors. We were not able to.

AB - Sexual and urinary side effects of prostate cancer treatment have been well described in the literature, but less is known about the psychosocial effects of prostate cancer treatment. Objective To prospectively evaluate physical and psychosocial functioning after diagnosis of prostate cancer and factors associ-ated with treatment satisfaction after prostate cancer treatment. Methods Patients diagnosed with prostate cancer at a university-based urology department were invited to participate in this internet-based study. Validated questionnaires were used to evaluate health-related quality of life (HRQoL) domains at pretreatment baseline following diagnosis and at 1, 3, 6, and 12 months after treatment. Domains of HRQoL included sexual, urinary, and bowel functioning; anxiety and depression; and sleep disturbance, pain, and fatigue. Linear repeated measures models were used to examine changes in self-reported measures at each time point. Results Of 105 men diagnosed with prostate cancer enrolled in the study, 54 completed assessments through 12 months. Decreased erectile function and sexual HRQoL following treatment were not significantly associated with worse treatment satisfac-tion over time. Instead, treatment satisfaction was significantly associated (P < .01) with anxiety (r, .28-.60), depression (r, .32-.48), fatigue (r, .40-.56), pain (r, .32-.61), sleep disturbance (r, .51-.59), and bladder problems (r, .41-.63). Limitations Not all patients were enrolled or completed all longitudinal questionnaires, which may bias the results because of unmeasurable factors. We were not able to.

UR - http://www.scopus.com/inward/record.url?scp=85049410829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049410829&partnerID=8YFLogxK

U2 - 10.12788/jcso.0401

DO - 10.12788/jcso.0401

M3 - Article

AN - SCOPUS:85049410829

VL - 16

SP - e130-e137

JO - Journal of Community and Supportive Oncology

JF - Journal of Community and Supportive Oncology

SN - 2330-7749

IS - 3

ER -